Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema

NCT00318513 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Lymphedema

Interventions

DRUG: Bevacizumab

Sponsor

Premiere Oncology of Arizona

Collaborators

[object Object]